| 000 | 01566 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250516144143.0 | ||
| 264 | 0 | _c20140204 | |
| 008 | 201402s 0 0 spa d | ||
| 022 | _a1578-8989 | ||
| 024 | 7 |
_a10.1016/j.medcli.2013.02.010 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aCabaleiro, Teresa | |
| 245 | 0 | 0 |
_a[Application of pharmacogenomics and other new technologies to drug development]. _h[electronic resource] |
| 260 |
_bMedicina clinica _cJun 2013 |
||
| 300 |
_a558-63 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aBiomarkers |
| 650 | 0 | 4 |
_aBiotransformation _xgenetics |
| 650 | 0 | 4 | _aClinical Trials, Phase I as Topic |
| 650 | 0 | 4 | _aClinical Trials, Phase II as Topic |
| 650 | 0 | 4 | _aDrug Approval |
| 650 | 0 | 4 | _aDrug Design |
| 650 | 0 | 4 | _aDrug Evaluation, Preclinical |
| 650 | 0 | 4 |
_aDrug Industry _xstatistics & numerical data |
| 650 | 0 | 4 |
_aDrug and Narcotic Control _xorganization & administration |
| 650 | 0 | 4 | _aGenomics |
| 650 | 0 | 4 | _aInventions |
| 650 | 0 | 4 | _aMetabolomics |
| 650 | 0 | 4 | _aMolecular Targeted Therapy |
| 650 | 0 | 4 | _aPatient Selection |
| 650 | 0 | 4 | _aPharmacogenetics |
| 650 | 0 | 4 |
_aPrecision Medicine _xtrends |
| 650 | 0 | 4 | _aProteomics |
| 650 | 0 | 4 | _aSafety-Based Drug Withdrawals |
| 650 | 0 | 4 | _aSample Size |
| 700 | 1 | _aPrieto-Pérez, Rocío | |
| 700 | 1 | _aOchoa, Dolores | |
| 700 | 1 | _aAbad-Santos, Francisco | |
| 773 | 0 |
_tMedicina clinica _gvol. 140 _gno. 12 _gp. 558-63 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.medcli.2013.02.010 _zAvailable from publisher's website |
| 999 |
_c22665561 _d22665561 |
||